Cargando…
Age-adjusted Charlson Comorbidity Index: A Simple Tool, but Needs Further Validation in COVID-19 Patients
How to cite this article: Selvam V, Srinivasan S. Age-adjusted Charlson Comorbidity Index: A Simple Tool, but Needs Further Validation in COVID-19 Patients. Indian J Crit Care Med 2021;25(9):963–964.
Autores principales: | Selvam, Velmurugan, Srinivasan, Shrikanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664041/ https://www.ncbi.nlm.nih.gov/pubmed/34963707 http://dx.doi.org/10.5005/jp-journals-10071-23973 |
Ejemplares similares
-
Doppler-estimated Carotid and Brachial Artery Flow as Surrogate for Cardiac Output: Needs Further Validation
por: Selvam, Velmurugan, et al.
Publicado: (2022) -
Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries
por: Dessai, Sampada B., et al.
Publicado: (2018) -
The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients
por: Zhou, Shi, et al.
Publicado: (2022) -
Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?
por: Barz, Melanie, et al.
Publicado: (2022) -
The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer
por: Wang, Zhe, et al.
Publicado: (2023)